Liposomal amphotericin B in hepatic candidosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8048832.
- Also identified by PMC identifier 1029884.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 4 year old girl treated with a standard chemotherapy protocol for acute lymphoblastic leukaemia developed hepatic candidosis during the consolidation phase. This relapsed after a prolonged course of amphotericin B and flucytosine. An eight week course of liposomal amphotericin produced a marked clinical improvement which was sustained for one year. A subsequent relapse was associated with transformation to myelodysplastic leukaemia.
Medical subject headings
- Amphotericin B
- Candidiasis
- Liver Diseases